HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. …

The SKYRIZI “Instructions for Use” contains more detailed instructions on the preparation and administration of SKYRIZI [see Instructions for Use]. Instruct the patient to read the Instructions for …

Get to know SKYRIZI, an FDA‐approved biologic treatment for adults with Ps, PsA, CD, & UC. See full Safety and Prescribing Information.

What is Skyrizi used for? Skyrizi is a prescription medicine used to treat adults with moderate to severe plaque psoriasis, an inflammatory condition affecting the skin and nails. Plaque psoriasis can cause …

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI.

Sep 16, 2025 · Skyrizi Injection package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Sep 3, 2025 · AbbVie Inc.: SKYRIZI is an interleukin-23 antagonist indicated for the treatment of: moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or …

SKYRIZI (risankizumab), an interleukin-23 blocker, is a humanised immunoglobin G1 (IgG1) monoclonal antibody. Risankizumab is produced in a mammalian cell line using recombinant DNA technology.

Nov 11, 2025 · Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Includes indications, doses, interactions, side effects and more.

2.5 Administration Instructions SKYRIZI is intended for use under the guidance and supervision of a healthcare professional. Patients may self-inject SKYRIZI after training in subcutaneous injection …